Pregnancy and Lactation

(083) Treatment Patterns Before, During, and After Pregnancy in Inflammatory Bowel Disease

(084) Patterns of antiseizure medications prescriptions among pregnant people with epilepsy: a utilization study in three Canadian provinces

(085) Trends and patterns of antiseizure medication prescribing during pregnancy between 1995 and 2018 in the United Kingdom

(086) Trends in the Use of Prescription Medications Among Women of Reproductive Age by Pregnancy Status in the U.S., 2009-2020

(087) Characteristics and Outcomes of Pregnant Patients and Their Infants in a Linked Maternal-Infant Administrative Claims Database

(088) Changes in Diclectin Utilization Trends in Ontario Following Media Attention: A Time-Series Analysis

(089) Application of a Structured Process to Identify Fit-for-Purpose Data for Pregnancy Database Study

(090) Use of Medication for Gastroesophageal Reflux During Pregnancy and Adverse Birth Outcomes

(091) Abortion-related Trends Before and After the Dobbs Decision within TriNetX Electronic Medical Record Data

(092) Trends in Medically Assisted Reproduction Utilization and Obstetrical as well as Perinatal Outcomes in Quebec between 2005 and 2015 - the Impact of the Universal Access Program: an interrupted time series analysis

(093) Expanding Pregnancy Surveillance Programs to Assess Effects of Medicinal Product Exposure During Lactation

(094) A first step in drug utilisation and safety studies: identifying indications for drug use in administrative data sources. A pilot study with gabapentinoids in a French healthcare data source. A contribution from the ConcePTION project

(095) Utilization of prescribed drugs in pregnancy between 2015 and 2021 in Switzerland: A retrospective analysis of Swiss healthcare claims data

(096) Medications considered to have substantial teratogenic risk commonly used in US pregnant population – quality of evidence and magnitude of risk

(097) Lactation Studies: When are healthy volunteers an option?

(098) Exposure to teratogens in pregnancy and in women of childbearing age between 2015 and 2021 in Switzerland: A retrospective analysis of Swiss healthcare claims data

(099) Patterns of prescription medication use during pregnancy in the United States, 1997–2018

(100) A Systematic Review of Secondary Databases Used in Paternal Drug Exposure Studies and Discussion of Paternal Exposure Related Pregnancy Outcomes

(101) Drug utilisation studies in pregnant women for newly licensed medicinal products: reflections from IMI-ConcePTION

(102) Development of Drug Trees to Support TreeScan Analyses of Prenatal Drug Exposures Associated with Fetal Cardiac Malformations

(103) Identification of Pregnancies Without a Recorded Outcome in German Claims Data

(104) Antiseizure medication use in pregnancy and adverse neonatal birth outcomes: a population-based cohort study

(105) Real-world prenatal exposure to topiramate among women of childbearing age and their contraceptive use in the USA

(106) Safety and Effectiveness of Insulin Aspart versus Other Bolus Insulins in Women with Pre-existing Type 1 Diabetes During Pregnancy

(107) The AMerican PREGNANcy-Mother-Child Cohort (AM-PREGNANT): Description and prevalence of main perinatal outcomes and medication use

(108) ADHD and induced abortion in young women: a population-based study from Norway

(109) Comparing prevalence of neural tube defects and orofacial clefts in Global Burden of Disease study and EUROCAT registry data

(110) Determinants of Participation in Clinical Trials During Pregnancy and Lactation

(111) Patterns of Antibiotic Utilization for Urinary Tract Infection During Pregnancy, 2007-2020

(112) Gabapentin use during pregnancy and adverse neonatal birth outcomes: a population-based cohort study

(113) Review of Mother-Infant Linkage Algorithms in Health Care Databases

(114) A Comparison of Postpartum Opioid Consumption and Opioid Discharge Prescriptions Among Opioid Naïve Patients and Those With Opioid Use Disorder

(115) Associations between Antibiotics and Non-Cardiac Birth Defects, National Birth Defects Prevention Study and Birth Defects Study to Evaluate Pregnancy Exposures

(116) Antibiotic exposure during pregnancy: prevalence and associated factors in a French population-based study (2010-2019)

(117) Time Trends of HIV Treatment in Girls and Women of Childbearing Age in Germany

(118) School readiness among children exposed to opioids during pregnancy in Manitoba, Canada

(119) Factors Associated with Health Plan Disenrollment During Pregnancy Among US Commercially Insured Women

(120) Maternal acetaminophen intake in pregnancy and the risk of childhood cancer

(121) Pregnancy and Fetal Outcomes Following Paternal Exposure to Glatiramer Acetate

(122) Antidepressant Use During Trimester One And Pregnancy Loss: A Causal Analysis In The UK CPRD

(123) Pregnancy and Fetal Outcomes Following Maternal Exposure to Glatiramer Acetate in 3 Trimesters of Pregnancy

(124) Use of multiple sclerosis disease-modifying therapies during pregnancy in France from 2010 to 2021

(125) Pregnancy Rates in Patients with Immune-mediated Inflammatory Diseases

(126) Long-Term Outcomes of Children exposed to RAAS-Inhibitors During Pregnancy

(127) Antidepressant and Psychotherapy Initiation Among Patients with New Episodes of Depression During Pregnancy

(128) Clinical Quality of Information of Primary Pregnancy Pharmacovigilance Data Sources – A ConcePTION Project

(129) Benefit-Risk Assessment Conceptual Framework for Exposure to Biologics during Pregnancy

(130) Lactation Studies of Biologics and Design Challenges

(131) Database profile: EPI-MERES, a nationwide mother-child register built from the French National Health Data System (SNDS) for pregnancy and paediatric pharmacoepidemiological research

(132) Using a causal framework and electronic health record data to infer the effects of antidepressant exposure in pregnancy

(133) Assessment of maternal acetaminophen use during pregnancy: a comparison of self-reported intake with maternal and newborn biomarker measures

(134) Core Evidence Elements for generating medicine safety evidence for pregnancy using population-based data: Recommendations from IMI-ConcePTION

(135) Congenital Heart Defects Among Infants Linked To Mothers In The Healthcore Integrated Research Database

(136) Specifying and mapping design choices from the protocol to the study script in a complex multi-database study to improve transparency and efficiency: the experience of a demonstration project in IMI-ConcePTION

(137) The Impact of Psychiatric Diseases and Antiepileptic Drugs Use in Pregnant Women with Epilepsy in Asia Population

(138) Monitoring pregnancies exposed to galcanezumab for migraine in a United States (US) administrative claims database

(139) Challenges and opportunities of European population-based data sources to support regulatory safety-related research questions in pregnancy

(140) Disruptions In Prenatal Care Visits During The Pandemic: A Population-Based Cohort Study in Manitoba, Canada

(141) Paxlovid Prophylaxis or Treatment in Pregnancy: Data from the Organization of Teratology Information Specialists (OTIS) Pregnancy Registry

(142) Health Literacy and Medication Adherence in Hypertensive Pregnant and Postpartum Patients: A Cross-sectional study

(143) A first step to study the use and safety of multiple sclerosis (MS) drugs during pregnancy: identifying cases of MS and assessing MS prevalence. A pilot study in a French health care datasource. A contribution from the ConcePTION project

(144) Antiseizure medication safety in pregnant people for non-epilepsy conditions

(145) Ponesimod Pregnancy Outcomes Enhanced Monitoring (POEM) Program to Evaluate Reproductive and Embryofetal Toxicity

(146) Prevalence of multiple sclerosis in women of childbearing age potential in Europe: A contribution from IMI ConCEPTION

(147) Association between non-steroid anti-inflammatory drugs use during pregnancy and premature birth in the NISAMI cohort

(148) Assesing the Safety of Antihypertensive medication in Pregnancy (ASAP project)

(149) First trimester exposure to smoking cessation pharmacotherapies and the risk of major congenital malformations: A multi-national cohort study

(150) Risk of Major Congenital Malformations Associated with Topical Retinoid Use in Pregnancy – Results From Nordic Population-Based Cohorts

(151) A Safety Comparison of Continuing Versus Discontinuing Triptans for Acute Migraine Treatment in Early Pregnancy

(152) To whom results apply? Assessing the impact of extended continuous enrollment inclusion criteria in pharmacoepidemiologic studies of medication use in pregnancy

(153) Patterns Of Antidepressant Prescribing During Pregnancy Between 1996 And 2018 Using The Clinical Practice Research Datalink

(154) Maternal mental health during the COVID-19 pandemic and its impact on child cognitive development

(155) Maternal Use of Benzodiazepines and Risk of Spontaneous Abortion: A Nationwide Case-Time Control Study

(156) The Impact of Nicotine Replacement Therapy on Maternal-Neonatal Outcomes and Smoking Cessation in Pregnant Women: A Systematic Review and Meta-Analysis